Y
Yoichi Nakamura
Researcher at Okayama University
Publications - 20
Citations - 817
Yoichi Nakamura is an academic researcher from Okayama University. The author has contributed to research in topics: Cardiac function curve & Heart failure. The author has an hindex of 11, co-authored 20 publications receiving 747 citations.
Papers
More filters
Journal ArticleDOI
Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium
Kazufumi Nakamura,Kengo Fukushima Kusano,Yoichi Nakamura,Mikio Kakishita,Keiko Ohta,Satoshi Nagase,Mika Yamamoto,Katsumasa Miyaji,Hironori Saito,Hiroshi Morita,Tetsuro Emori,Hiromi Matsubara,Shinya Toyokuni,Tohru Ohe +13 more
TL;DR: Oxidative stress is elevated in myocardia of patients with heart failure and administration of carvedilol resulted in a decrease in the oxidative stress level together with amelioration of cardiac function.
Journal ArticleDOI
Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis.
Yoichi Nakamura,Kazufumi Nakamura,Kengo Fukushima-Kusano,Keiko Ohta,Hiromi Matsubara,Tsutomu Hamuro,Chikao Yutani,Tohru Ohe +7 more
TL;DR: Tissue factor expression induced by local inflammation is involved in the pathogenesis of thrombosis in patients with nonvalvular atrial fibrillation and cardiogenic thromboembolism.
Journal ArticleDOI
Relationship between oxidative stress and systolic dysfunction in patients with hypertrophic cardiomyopathy
Kazufumi Nakamura,Kengo Fukushima Kusano,Hiromi Matsubara,Yoichi Nakamura,Aya Miura,Nobuhiro Nishii,Kimikazu Banba,Satoshi Nagase,Katsumasa Miyaji,Hiroshi Morita,Hironori Saito,Tetsuro Emori,Tohru Ohe +12 more
TL;DR: Oxidative stress was elevated in myocardia of HCM patients and the levels were correlated with left ventricular dilatation and systolic dysfunction, suggesting oxidative stress is involved in the pathogenesis of heart failure in patients with HCM.
Journal ArticleDOI
Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis.
Kengo Kusano,Kazufumi Nakamura,Hitoshi Kusano,Nobuhiro Nishii,Kimikazu Banba,Tetsuya Ikeda,Katsushi Hashimoto,Mika Yamamoto,Hideki Fujio,Aya Miura,Keiko Ohta,Hiroshi Morita,Hironori Saito,Tetsuro Emori,Yoichi Nakamura,Isao Kusano,Tohru Ohe +16 more
TL;DR: An increase in MCP-1 may be an important factor in the progression of atherosclerosis in non-diabetic HD patients.
Journal ArticleDOI
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus.
Kentaro Ejiri,Toru Miyoshi,Hajime Kihara,Yoshiki Hata,Toshihiko Nagano,Atsushi Takaishi,Hironobu Toda,Seiji Nanba,Yoichi Nakamura,Satoshi Akagi,Satoru Sakuragi,Taro Minagawa,Yusuke Kawai,Nobuhiro Nishii,Soichiro Fuke,Masaki Yoshikawa,Kazufumi Nakamura,Hiroshi Ito +17 more
TL;DR: In patients with type 2 diabetes mellitus and HFpEF, there is no significant difference in the degree of reduction in BNP concentrations after 12 weeks between luseogliflozin and voglibose.